🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › California › Sacramento

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Sacramento, CA keessatti

Qorannoo 8 Diffuse Large B-Cell Lymphoma f Sacramento fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Namoota walitti qabaa jiraSadarkaa 2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06500273

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • UC Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06091865

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT05272384

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT05052528

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT06015880

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

Namoota walitti qabaa jiraSadarkaa 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT06854159

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06905509

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT05256641

Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti

Qorannoo biroo Sacramento keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.